Evaluation of the Relationships Between Irisin Levels and Cognitive Functions in Individuals with Schizophrenia

Overview

Journal Clin Psychopharmacol Neurosci

Specialty Psychiatry

Date 2023 Oct 20

PMID 37859445

Authors

Hatice Ayca Kaloglu

Sibel Orsel

Gamze Erzin

Affiliations

Soon will be listed here.

Abstract

Objective: : Irisin is a myokine that is involved in neurogenesis, neuronal proliferation, and neuronal differentiation. Many research examine the relationship between irisin and schizophrenia. In this study, we aimed to evaluate the relationship between irisin levels and cognitive functions in individuals with schizophrenia.

Methods: : Ninety-six individuals who were diagnosed with schizophrenia were included. The Brief Psychiatric Rating Scale (BPRS) was used to assess disease severity. To evaluate the cognitive functions of the patients, the trail-making test was evaluated with the A and B forms and the verbal memory processes scale. After a 12-hour night fast, samples of fasting blood were obtained from the participants.

Results: : There was no significant correlation between irisin, duration of disease, and BPRS total score. In the analysis performed, a positive correlation was found between the plasma irisin level and the error score of the trail-making test form B. Other than that, no correlation was found between irisin level and cognitive performance in schizophrenia patients. In addition, in subgroup analysis between genders, it was determined that the duration of the trail-making test B was longer in female schizophrenia patients.

Conclusion: : In this study, there was a positive correlation between the trail-making test B-form error scores and the irisin levels. This relationship between impaired executive functions and irisin levels may suggest that the irisin level is increased as compensation for the impairment in executive functions. More research is needed to understand the role of irisin in cognitive impairment and schizophrenia.

References

Moon H, Dincer F, Mantzoros C . Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism. 2013; 62(8):1131-6. PMC: 4370428. DOI: 10.1016/j.metabol.2013.04.007. View

Mohamed S, Paulsen J, OLeary D, Arndt S, Andreasen N . Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry. 1999; 56(8):749-54. DOI: 10.1001/archpsyc.56.8.749. View

Dun S, Lyu R, Chen Y, Chang J, Luo J, Dun N . Irisin-immunoreactivity in neural and non-neural cells of the rodent. Neuroscience. 2013; 240:155-62. PMC: 3637839. DOI: 10.1016/j.neuroscience.2013.02.050. View

Peng J, Deng X, Huang W, Yu J, Wang J, Wang J . Irisin protects against neuronal injury induced by oxygen-glucose deprivation in part depends on the inhibition of ROS-NLRP3 inflammatory signaling pathway. Mol Immunol. 2017; 91:185-194. DOI: 10.1016/j.molimm.2017.09.014. View

Bowie C, Harvey P . Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2009; 2(4):531-6. PMC: 2671937. DOI: 10.2147/nedt.2006.2.4.531. View

Wrann C, White J, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D . Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013; 18(5):649-59. PMC: 3980968. DOI: 10.1016/j.cmet.2013.09.008. View

Hashemi M, Ghaedi K, Salamian A, Karbalaie K, Emadi-Baygi M, Tanhaei S . Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells. Neuroscience. 2012; 231:296-304. DOI: 10.1016/j.neuroscience.2012.11.041. View

Lourenco M, Ribeiro F, Sudo F, Drummond C, Assuncao N, Vanderborght B . Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer's disease. Alzheimers Dement (Amst). 2020; 12(1):e12034. PMC: 7306518. DOI: 10.1002/dad2.12034. View

Hoff A, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi L . Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am J Psychiatry. 1999; 156(9):1336-41. DOI: 10.1176/ajp.156.9.1336. View

10.

Bostrom P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J . A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. PMC: 3522098. DOI: 10.1038/nature10777. View

11.

Heyn P, Abreu B, Ottenbacher K . The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil. 2004; 85(10):1694-704. DOI: 10.1016/j.apmr.2004.03.019. View

12.

Fagundo A, Jimenez-Murcia S, Giner-Bartolome C, Aguera Z, Sauchelli S, Pardo M . Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity. Sci Rep. 2016; 6:30820. PMC: 4967861. DOI: 10.1038/srep30820. View

13.

Zsuga J, Tajti G, Papp C, Juhasz B, Gesztelyi R . FNDC5/irisin, a molecular target for boosting reward-related learning and motivation. Med Hypotheses. 2016; 90:23-8. DOI: 10.1016/j.mehy.2016.02.020. View

14.

Green M . What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996; 153(3):321-30. DOI: 10.1176/ajp.153.3.321. View

15.

Green M, Kern R, Braff D, Mintz J . Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull. 2001; 26(1):119-36. DOI: 10.1093/oxfordjournals.schbul.a033430. View

16.

Bowie C, Harvey P . Administration and interpretation of the Trail Making Test. Nat Protoc. 2007; 1(5):2277-81. DOI: 10.1038/nprot.2006.390. View

17.

Robins Wahlin T, Backman L, Wahlin A, Winblad B . Trail Making Test performance in a community-based sample of healthy very old adults: effects of age on completion time, but not on accuracy. Arch Gerontol Geriatr. 1996; 22(1):87-102. DOI: 10.1016/0167-4943(95)00681-8. View

18.

Smith J, Nielson K, Woodard J, Seidenberg M, Durgerian S, Antuono P . Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders. Neuroimage. 2010; 54(1):635-44. PMC: 2962671. DOI: 10.1016/j.neuroimage.2010.07.070. View

19.

Szuhany K, Bugatti M, Otto M . A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J Psychiatr Res. 2014; 60:56-64. PMC: 4314337. DOI: 10.1016/j.jpsychires.2014.10.003. View

20.

Vakil E, Blachstein H, Sheinman M, Greenstein Y . Developmental changes in attention tests norms: implications for the structure of attention. Child Neuropsychol. 2008; 15(1):21-39. DOI: 10.1080/09297040801947069. View